1105 Tumor cell autonomous innate immune signaling drives therapeutic resistance in head and neck tumors

Bibliographic Details
Main Authors: Curtis Perry, Barbara Burtness, Kelly Olino, Lotus Lum, Jeffrey Ishizuka, Alexander Frey, Kathyrn Clulo, Mackenzie Bender
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer
_version_ 1797630804300398592
author Curtis Perry
Barbara Burtness
Kelly Olino
Lotus Lum
Jeffrey Ishizuka
Alexander Frey
Kathyrn Clulo
Mackenzie Bender
author_facet Curtis Perry
Barbara Burtness
Kelly Olino
Lotus Lum
Jeffrey Ishizuka
Alexander Frey
Kathyrn Clulo
Mackenzie Bender
author_sort Curtis Perry
collection DOAJ
first_indexed 2024-03-11T11:14:00Z
format Article
id doaj.art-faa15d6ca64b4ffa855fcdd6e0434536
institution Directory Open Access Journal
issn 2051-1426
language English
last_indexed 2024-03-11T11:14:00Z
publishDate 2023-11-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj.art-faa15d6ca64b4ffa855fcdd6e04345362023-11-11T11:35:07ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.11051105 Tumor cell autonomous innate immune signaling drives therapeutic resistance in head and neck tumorsCurtis Perry0Barbara Burtness1Kelly Olino2Lotus Lum3Jeffrey Ishizuka4Alexander Frey5Kathyrn Clulo6Mackenzie Bender75Yale University, New Haven, CT, USAAff8 grid.47100.320000000419368710Yale University School of Medicine New Haven CT USAAff1 0000000419368710grid.47100.32Section of Surgical OncologyYale School of Medicine 20 Park Street 06519 New Haven CT USAUniversity of California, San Francisco, San Francisco, CA, USA6Yale University, Woodbridge, CT1Yale University, New Haven, CT, USA1Yale University, New Haven, CT, USA2Yale New Haven Hospital, Department of Surgical Oncology, New Haven, CT, USA
spellingShingle Curtis Perry
Barbara Burtness
Kelly Olino
Lotus Lum
Jeffrey Ishizuka
Alexander Frey
Kathyrn Clulo
Mackenzie Bender
1105 Tumor cell autonomous innate immune signaling drives therapeutic resistance in head and neck tumors
Journal for ImmunoTherapy of Cancer
title 1105 Tumor cell autonomous innate immune signaling drives therapeutic resistance in head and neck tumors
title_full 1105 Tumor cell autonomous innate immune signaling drives therapeutic resistance in head and neck tumors
title_fullStr 1105 Tumor cell autonomous innate immune signaling drives therapeutic resistance in head and neck tumors
title_full_unstemmed 1105 Tumor cell autonomous innate immune signaling drives therapeutic resistance in head and neck tumors
title_short 1105 Tumor cell autonomous innate immune signaling drives therapeutic resistance in head and neck tumors
title_sort 1105 tumor cell autonomous innate immune signaling drives therapeutic resistance in head and neck tumors
work_keys_str_mv AT curtisperry 1105tumorcellautonomousinnateimmunesignalingdrivestherapeuticresistanceinheadandnecktumors
AT barbaraburtness 1105tumorcellautonomousinnateimmunesignalingdrivestherapeuticresistanceinheadandnecktumors
AT kellyolino 1105tumorcellautonomousinnateimmunesignalingdrivestherapeuticresistanceinheadandnecktumors
AT lotuslum 1105tumorcellautonomousinnateimmunesignalingdrivestherapeuticresistanceinheadandnecktumors
AT jeffreyishizuka 1105tumorcellautonomousinnateimmunesignalingdrivestherapeuticresistanceinheadandnecktumors
AT alexanderfrey 1105tumorcellautonomousinnateimmunesignalingdrivestherapeuticresistanceinheadandnecktumors
AT kathyrnclulo 1105tumorcellautonomousinnateimmunesignalingdrivestherapeuticresistanceinheadandnecktumors
AT mackenziebender 1105tumorcellautonomousinnateimmunesignalingdrivestherapeuticresistanceinheadandnecktumors